Safety, Tolerability and Pharmacokinetics of Liposomal Curcumin in Healthy Volunteers - A Phase I Dose Escalation Study.
Phase of Trial: Phase I
Latest Information Update: 15 Dec 2014
At a glance
- Drugs Curcumin (Primary)
- Indications Breast cancer; Cancer; Conduction disorders; Lymphoma; Pancreatic cancer; Parkinson's disease
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Signpath Pharma
- 09 Apr 2013 Results presented at the 104th Annual Meeting of the American Association for Cancer Research.
- 08 Sep 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 20 Sep 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History